UNIVERSITE PARIS CITE

Their core work

Université Paris Cité is a major French research university formed from the merger of Paris Diderot and Paris Descartes, with deep strengths in biomedical sciences, quantum physics, and data-driven health research. Their H2020 portfolio reveals a university that trains the next generation of researchers through Marie Skłodowska-Curie and ERC programmes while running substantial clinical and translational research — particularly in inflammatory bowel disease, personalized medicine, and cancer. They also maintain a strong fundamental physics programme spanning quantum optics, ultracold gases, and nanofluidics, alongside growing capabilities in machine learning applied to biomedical data.

What they specialise in

How they've shifted over time

In the early H2020 period (2014–2018), Université Paris Cité focused on clinical gastroenterology (Crohn's disease treatment cycles, paediatric IBD safety), developmental language disorders (bilingualism, dyslexia, EEG-based prediction), and foundational training networks. From 2019 onward, the portfolio shifted markedly toward data-intensive biomedical research — machine learning, microbiome analysis, multi-omics, and precision medicine — while simultaneously expanding a quantum physics cluster covering ultracold atoms, quantum cascade technologies, and entanglement. This dual evolution suggests a university deliberately building computational and quantum capabilities on top of its established clinical and life science base.

Université Paris Cité is converging machine learning with biomedical data at scale, making them an increasingly attractive partner for projects at the intersection of AI and health.

How they like to work

With 29 projects as coordinator and 47 as participant, Université Paris Cité is comfortable both leading and contributing — but notably, 30 projects list them as third party, reflecting their complex multi-entity structure where affiliated labs participate through the umbrella university. Their network of 925 unique partners across 56 countries signals a true hub institution that builds broad, diverse consortia rather than relying on a small circle of repeat collaborators. Expect a well-organized partner with experience managing large international networks, though coordination may involve navigating internal departmental structures.

With 925 unique consortium partners spanning 56 countries, Université Paris Cité operates one of the broadest collaboration networks among French universities in H2020. Their reach is genuinely global, though the heaviest collaboration density is within the European Research Area.

What sets them apart

Université Paris Cité combines a top-tier medical faculty (one of France's largest, with direct hospital access through AP-HP) with strong fundamental physics and growing data science capabilities — a combination few European universities can match under one roof. Their high number of MSCA and ERC grants demonstrates individual researcher excellence, not just institutional scale. For consortium builders, this means access to both clinical cohorts and computational expertise in a single partnership, reducing the need for multiple specialized partners.

Highlights from their portfolio

• INSPIRE
  Largest single grant (EUR 4.7M) — an interdisciplinary doctoral training network coordinated by UPCité, demonstrating their capacity to manage large-scale international researcher training.
• PIBD-SETQuality
  Coordinated a EUR 580K network focused on paediatric inflammatory bowel disease safety and treatment quality — a niche where UPCité holds recognized European leadership.
• VIRUSCAN
  Combined optomechanics with virology (EUR 856K), exemplifying UPCité's ability to bridge fundamental physics and life sciences in unconventional ways.